Discovery Of Potent Inhibitors Against P-Glycoprotein-Mediated Multidrug Resistance Aided By Late-Stage Functionalization Of A 2-(4-(Pyridin-2-Yl)Phenoxy)Pyridine Analogue

JOURNAL OF MEDICINAL CHEMISTRY(2020)

Cited 30|Views9
No score
Abstract
SIS3 is a specific inhibitor of Smad3 that inhibits the TGF beta 1-induced phosphorylation of Smad3. In this article, a variety of SIS3 derivatives were designed and synthesized to discover potential inhibitors against P-glycoprotein-mediated multidrug resistance aided by late-stage functionalization of a 2-(4-(pyridin-2-yl)phenoxy)pyridine analogue. A novel class of potent P-gp reversal agents were investigated, and a lead compound 37 was identified as a potent P-gp reversal agent with strong bioactivity and outstanding affinity for P-gp.
More
Translated text
Key words
potent inhibitors,multidrug,p-glycoprotein-mediated,late-stage
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined